Choksi Laboratories Ltd

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Choksi Laboratories Ltd., a contract testing and analytical services provider, reported a sharp recovery in quarterly profit for Q4 FY26, with net profit surging to ₹1.03 crores—a dramatic 232.26% increase quarter-on-quarter and 11.96% year-on-year. However, beneath this headline improvement lies a concerning narrative of operational challenges, elevated debt levels, and weak returns on capital that continue to constrain the micro-cap company's investment appeal. Trading at ₹140.00 with a market capitalisation of ₹98.00 crores, the stock has gained 29.21% over the past year but remains 40.85% below its 52-week high of ₹236.70.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 May 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain subdued. The stock’s recent price surge of 12.42% and improved technical signals contrast with flat quarterly financials and weak long-term fundamentals, presenting a complex picture for investors.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 18 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and concerns over valuation and long-term fundamentals, signalling caution for investors amid a challenging market environment.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 11 May 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors.

Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 4 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weak fundamental metrics, signalling heightened risks for investors amid challenging market conditions.

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental and financial metrics remain under pressure. The revised rating highlights a mild improvement in technical indicators, balanced against persistent challenges in valuation and financial trends.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating as of 7 April 2026. The downgrade reflects deteriorating technical indicators, flat financial performance, and weak long-term fundamentals, signalling caution for investors amid challenging market conditions.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing fundamental challenges, signalling a cautious but slightly more optimistic stance from analysts.

Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 March 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and ongoing valuation concerns, signalling heightened risks for investors amid a challenging market environment.

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental challenges, prompting a reassessment of its valuation and market positioning.

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Choksi Laboratories Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.81.85 today, marking a significant decline amid ongoing market pressures and sector underperformance. The stock’s recent performance highlights persistent challenges reflected in its valuation and financial metrics.

Choksi Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Choksi Laboratories Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 17 Feb 2026. This shift reflects deteriorating technical indicators, stagnant financial performance, and a challenging valuation backdrop, signalling caution for investors amid underwhelming market returns and weak fundamental metrics.

Choksi Laboratories Ltd, a healthcare services company, has seen its investment rating downgraded from Strong Sell to Sell following a reassessment of its financial performance, valuation, technical indicators, and overall quality metrics. The downgrade reflects a cautious stance amid flat quarterly results, subdued financial trends, and mixed technical signals, despite some attractive valuation parameters.